United Therapeutics Corporation
Martine A Rothblatt (Chairperson & CEO) sells UTHR shares
AI-generated summary
Chairperson & CEO, Director Martine A Rothblatt exercised 9,500 stock options for 9,500 shares of Common Stock valued at $1,118,720 and sold 9,500 shares of Common Stock for $5,570,085.26 indirectly by Trust. Following these transactions, the insider held 324,443 shares indirectly by Trust. The transactions were executed under a Rule 10b5-1 trading plan adopted on November 7, 2025.
Key facts
- Insider
- Martine A Rothblatt · Chairperson & CEO, Director
Rule 10b5-1 plan · adopted Nov 7, 2025
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | M · exercise or conversion of a derivativeFootnotes F1, F2 | +9,500 | $117.76 | $1,118,720.00 | 333,943 | Indirect (by Trust) |
| Nov 10, 2026 | S · open-market saleFootnotes F1, F2 | −40 | $577.52 | $23,100.80 | 333,903 | Indirect (by Trust) |
| Nov 10, 2026 | S · open-market saleFootnotes F1, F3, F2 | −880 | $580.40 | $510,755.70 | 333,023 | Indirect (by Trust) |
| Nov 10, 2026 | S · open-market saleFootnotes F1, F4, F2 | −742 | $581.36 | $431,366.89 | 332,281 | Indirect (by Trust) |
| Nov 10, 2026 | S · open-market saleFootnotes F1, F5, F2 | −618 | $582.42 | $359,937.35 | 331,663 | Indirect (by Trust) |
| Nov 10, 2026 | S · open-market saleFootnotes F1, F6, F2 | −980 | $583.64 | $571,963.87 | 330,683 | Indirect (by Trust) |
| Nov 10, 2026 | S · open-market saleFootnotes F1, F7, F2 | −328 | $584.76 | $191,800.89 | 330,355 | Indirect (by Trust) |
| Nov 10, 2026 | S · open-market saleFootnotes F1, F8, F2 | −795 | $585.56 | $465,516.78 | 329,560 | Indirect (by Trust) |
| Nov 10, 2026 | S · open-market saleFootnotes F1, F9, F2 | −937 | $586.66 | $549,698.08 | 328,623 | Indirect (by Trust) |
| Nov 10, 2026 | S · open-market saleFootnotes F1, F10, F2 | −620 | $587.96 | $364,535.57 | 328,003 | Indirect (by Trust) |
| Nov 10, 2026 | S · open-market saleFootnotes F1, F11, F2 | −360 | $589.15 | $212,092.78 | 327,643 | Indirect (by Trust) |
| Nov 10, 2026 | S · open-market saleFootnotes F1, F12, F2 | −2,040 | $589.95 | $1,203,502.49 | 325,603 | Indirect (by Trust) |
| Nov 10, 2026 | S · open-market saleFootnotes F1, F13, F2 | −960 | $590.95 | $567,315.36 | 324,643 | Indirect (by Trust) |
| Nov 10, 2026 | S · open-market saleFootnotes F1, F14, F2 | −120 | $592.20 | $71,064.31 | 324,523 | Indirect (by Trust) |
| Nov 10, 2026 | S · open-market saleFootnotes F1, F15, F2 | −80 | $592.93 | $47,434.40 | 324,443 | Indirect (by Trust) |
| Nov 10, 2026 | M · exercise or conversion of a derivativeStock OptionFootnotes F1, F19, F20 | −9,500 | $0.00 | $0.00 | 52,910 | Indirect (by Trust) |
Footnotes
- F1 This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10 This transaction was executed in multiple trades at prices ranging from $587.52 to $588.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11 This transaction was executed in multiple trades at prices ranging from $588.62 to $589.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12 This transaction was executed in multiple trades at prices ranging from $589.65 to $590.525. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13 This transaction was executed in multiple trades at prices ranging from $590.69 to $591.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14 This transaction was executed in multiple trades at prices ranging from $591.85 to $592.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F15 This transaction was executed in multiple trades at prices ranging from $592.91 to $592.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F16 Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F17 Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F18 Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F19 These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.
- F2 Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F20 Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F3 This transaction was executed in multiple trades at prices ranging from $579.91 to $580.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4 This transaction was executed in multiple trades at prices ranging from $580.99 to $581.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5 This transaction was executed in multiple trades at prices ranging from $582.00 to $582.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6 This transaction was executed in multiple trades at prices ranging from $583.10 to $584.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7 This transaction was executed in multiple trades at prices ranging from $584.14 to $585.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8 This transaction was executed in multiple trades at prices ranging from $585.15 to $586.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9 This transaction was executed in multiple trades at prices ranging from $586.16 to $587.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
More UTHR filings
- 4
Filed Nov 12, 2026
- 4
Filed Nov 10, 2026
- 4
Filed Nov 10, 2026
- 4
Filed Nov 10, 2026
- 4
Filed Nov 9, 2026
- 144
Filed Nov 9, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.